VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 669 filers reported holding VANECK VECTORS ETF TR in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $31,236,000 | +14.7% | 814,500 | -4.2% | 3.61% | -32.4% |
| Q4 2021 | $27,226,000 | -8.0% | 850,000 | -15.4% | 5.35% | +6.3% |
| Q3 2021 | $29,609,000 | -13.3% | 1,004,700 | 0.0% | 5.03% | -46.6% |
| Q2 2021 | $34,140,000 | +5.0% | 1,004,700 | +0.5% | 9.43% | -24.0% |
| Q1 2021 | $32,500,000 | +10.2% | 1,000,000 | +22.1% | 12.40% | +4.0% |
| Q4 2020 | $29,502,000 | +123.8% | 819,054 | +143.4% | 11.92% | +187.3% |
| Q3 2020 | $13,180,000 | +86.1% | 336,554 | +74.3% | 4.15% | +21.4% |
| Q2 2020 | $7,083,000 | +85.1% | 193,116 | +16.3% | 3.42% | +169.6% |
| Q1 2020 | $3,827,000 | -6.7% | 166,116 | +18.6% | 1.27% | -45.3% |
| Q4 2019 | $4,103,000 | – | 140,116 | – | 2.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |